Previous 10 | Next 10 |
home / stock / hls:cc / hls:cc news
K-Bro Linen Inc. (KBL:CA) is expected to report $0.57 for Q3 2023 Yellow Pages Limited (Y:CA) is expected to report for Q3 2023 Ascot Resources Ltd. (AOT:CA) is expected to report for Q3 2023 Park Lawn Corporation (PLC:CA) is expected to report $0.27 for Q3 2023 Hut 8 Mining Corp....
HLS Therapeutics Inc. (HLS:CA) is expected to report $-0.16 for Q3 2023
HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Oct. 26, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 Fiscal 2023 financial results on Thur...
HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference Canada NewsWire TORONTO , Sept. 6, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS"...
HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results Canada NewsWire TORONTO , Aug. 10, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular mark...
HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Aug. 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 Fiscal 2023 financial results on Thursday, ...
HLS Therapeutics Announces Updates to its Board of Directors Canada NewsWire John Welborn, Jr. is appointed Chair of the Board, succeeding Greg Gubitz , who is retiring John Hanna is appointed to the HLS Board as an independent director ...
HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors Canada NewsWire HLS Directors J. Spencer Lanthier and Don DeGolyer will not be standing for re-election at the 2023 AGM ...
HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results Canada NewsWire TORONTO , May 11, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular markets, a...
HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , May 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 Fiscal 2023 financial results on Thursday, M...
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc. Company Name:
HLS:CC Stock Symbol:
TSXC Market:
HLS Therapeutics Inc. Website:
HLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug Plan Canada NewsWire With the addition of Alberta's public plan, Vascepa will be available to more than 90% of Canadians who are eligible and covered by a public or private plan. ...
HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO , July 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 fiscal 2024 financial results on Thur...
A look at the top 10 most actives in Canada Alaska Energy Metals Corporation (AEMC) rose 1.7% to $0.3 on volume of 2,135,498 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 6.0% to $2.83 on volume of 1,507,663 shares Givex Corp. (GIVX) rose 0.0% to $0.88 on volume of 1,150,...